Description Laboratories isolating human NK cells from whole blood need to remove non-NK cells while keeping the target NK cells unlabeled for downstream experiments. The K005 Human NK Cell Purification...

Description Expanding human natural killer (NK) cells while maintaining consistent cell quality can be challenging during immune cell research workflows. Researchers often encounter limitations including variable expansion performance, serum-related batch...

Description Reliable organoid banking can be difficult because organoids are multicellular three-dimensional structures rather than uniform single-cell suspensions. Inadequate freezing conditions may lead to cryoinjury, structural disruption, delayed post-thaw recovery,...

Description Reliable intestinal organoid establishment begins with the recovery of intact, viable intestinal crypts. During conventional intestinal tissue digestion, insufficient dissociation can leave crypts trapped within the mucosa, while excessive...

Description Establishing organoid cultures from primary tissue requires sufficient tissue dissociation without excessive digestion. Incomplete digestion may leave large tissue fragments that are difficult to process, while overly aggressive treatment...

Description Generating mesenchymal-like stem cells from induced pluripotent stem cells can be difficult to standardize across routine laboratory workflows. Variations in embryoid body formation, cell seeding, attachment, medium transitions, and...

Description Maintaining long-term viability and pluripotent characteristics after cryopreservation remains a critical challenge in human pluripotent stem cell workflows. During freezing and recovery processes, iPSC and ESC cultures may experience...

Description AMMS® organoid-specific matrix gel is made from basement membrane components extracted from mouse tumor tissues, and its main components include laminin, type IV collagen, heparin sulfate proteoglycans, etc. These...